STAAR/$STAA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About STAAR
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
Ticker
$STAA
Sector
Primary listing
Employees
921
Headquarters
Website
STAAR Metrics
BasicAdvanced
$911M
-
-$1.62
1.05
-
Price and volume
Market cap
$911M
Beta
1.05
52-week high
$30.81
52-week low
$14.69
Average daily volume
1.4M
Financial strength
Current ratio
4.548
Quick ratio
3.53
Long term debt to equity
9.437
Total debt to equity
11.143
Profitability
EBITDA (TTM)
-37.419
Gross margin (TTM)
76.19%
Net profit margin (TTM)
-33.60%
Operating margin (TTM)
-19.10%
Effective tax rate (TTM)
2.21%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
-5.95%
Return on equity (TTM)
-21.70%
Valuation
Price to revenue (TTM)
3.807
Price to book
2.64
Price to tangible book (TTM)
2.91
Price to free cash flow (TTM)
-22.76
Free cash flow yield (TTM)
-4.39%
Free cash flow per share (TTM)
-0.808
Growth
Revenue change (TTM)
-23.72%
Earnings per share change (TTM)
294.54%
3-year revenue growth (CAGR)
-5.57%
10-year revenue growth (CAGR)
12.00%
3-year earnings per share growth (CAGR)
26.59%
10-year earnings per share growth (CAGR)
25.31%
What the Analysts think about STAAR
Analyst ratings (Buy, Hold, Sell) for STAAR stock.
STAAR Financial Performance
Revenues and expenses
STAAR Earnings Performance
Company profitability
STAAR News
AllArticlesVideos
STAAR Surgical Issues Shareholder Letter
Business Wire·1 week ago
FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
Business Wire·3 weeks ago
STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence
Benzinga·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for STAAR stock?
STAAR (STAA) has a market cap of $911M as of March 13, 2026.
What is the P/E ratio for STAAR stock?
The price to earnings (P/E) ratio for STAAR (STAA) stock is 0 as of March 13, 2026.
Does STAAR stock pay dividends?
No, STAAR (STAA) stock does not pay dividends to its shareholders as of March 13, 2026.
When is the next STAAR dividend payment date?
STAAR (STAA) stock does not pay dividends to its shareholders.
What is the beta indicator for STAAR?
STAAR (STAA) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.